The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Characteristics associated with spatially resolved immune landscapes in triple-negative breast cancer in the FinXX trial and Mayo Clinic cohort.
 
Saranya Chumsri
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Athenex; Athenex; bioTheranostics; bioTheranostics (Inst); Eisai; Immunomedics; Immunomedics; Immunomedics; Novartis; Novartis; Puma Biotechnology; Seagen; Syndax
Research Funding - Array BioPharma; Merck; Salix
 
Jodi M Carter
No Relationships to Disclose
 
Yaohua Ma
No Relationships to Disclose
 
Douglas Hinerfeld
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Travel, Accommodations, Expenses - NanoString Technologies
 
Heather Ann Brauer
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
Travel, Accommodations, Expenses - NanoString Technologies
 
Sarah Warren
Employment - NanoString Technologies
Stock and Other Ownership Interests - NanoString Technologies
 
Heikki Joensuu
No Relationships to Disclose
 
Edith A. Perez
Employment - Bolt Biotherapeutics; Genentech
Leadership - Bolt Biotherapeutics
Stock and Other Ownership Interests - Genentech/Roche
Consulting or Advisory Role - Daiichi Sankyo; Puma Biotechnology; Seagen
 
Roberto Antonio Leon-Ferre
Consulting or Advisory Role - AstraZeneca (Inst); Gilead Sciences (Inst); Lyell Immunopharma (Inst)
 
David Zahrieh
No Relationships to Disclose
 
David W. Hillman
No Relationships to Disclose
 
Judy Caroline Boughey
Honoraria - PeerView; PER; UpToDate
Consulting or Advisory Role - CairnSurgical; SymBioSis (Inst)
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
 
James N. Ingle
No Relationships to Disclose
 
Krishna Rani Kalari
No Relationships to Disclose
 
Fergus Couch
Honoraria - Ambry Genetics/Konica Minolta; Natera; US Oncology Network
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Ambry Genetics; Qiagen
Research Funding - GRAIL
Travel, Accommodations, Expenses - GRAIL
Other Relationship - Ambry Genetics
 
Matthew P. Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); AstraZeneca (Inst); bioTheranostics (Inst); Blueprint Medicines (Inst); Genzyme (Inst); Lilly (Inst); Rna Diagnostics (Inst); Seagen (Inst)
Research Funding - Lilly (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly
 
Keith L. Knutson
Leadership - AffyImmune Therapeutics; Kiromic
Stock and Other Ownership Interests - Kiromic
Research Funding - Marker Therapeutics
Patents, Royalties, Other Intellectual Property - Mayo Clinic holds several patents of technologies that I have developed.
 
E Aubrey Thompson
No Relationships to Disclose